Related references
Note: Only part of the references are listed.Article Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
Daryl Geers et al.
ISCIENCE (2023)
Antibodies face the challenge against human respiratory syncytial virus
Rory D. de Vries et al.
CELL HOST & MICROBE (2023)
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
Daryl Geers et al.
ISCIENCE (2023)
Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates
Tomer Zohar et al.
CELL HOST & MICROBE (2022)
Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination
Vijaykrishna Dhanasekaran et al.
NATURE COMMUNICATIONS (2022)
Antibody effector functions are associated with protection from respiratory syncytial virus
Yannic C. Bartsch et al.
CELL (2022)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions
Opeyemi S. Adeniji et al.
MBIO (2021)
Is a Universal Influenza Virus Vaccine Possible?
Raffael Nachbagauer et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay
Veronika Chromikova et al.
VACCINE (2020)
Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response
Rory D. de Vries et al.
VIRUS RESEARCH (2020)
Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity
Rory D. de Vries et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
Rory D. de Vries et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection
Rory D. de Vries et al.
VACCINE (2017)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Influenza virus A(H1N1) 2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic
Annelies W. Mesman et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
Wenqian He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Joost H. C. M. Kreijtz et al.
LANCET INFECTIOUS DISEASES (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Detection of influenza A virus homo- and heterosubtype-specific memory B-cells using a novel protein microarray-based analysis tool
Dominique C. Baas et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination
Elisabeth G. W. Huijskens et al.
PLOS ONE (2013)
Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
Bjorn F. Koel et al.
SCIENCE (2013)
Profiling of humoral immune responses to influenza viruses by using protein microarray
M. Koopmans et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Course of pandemic influenza A(H1N1) 2009 virus infection in Dutch patients
Ingrid H. M. Friesema et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2012)
Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
R. Bodewes et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins
Lotte H. Hendrikx et al.
VACCINE (2011)
The evolutionary dynamics of human influenza B virus
Rubing Chen et al.
JOURNAL OF MOLECULAR EVOLUTION (2008)
Mapping the antigenic and genetic evolution of influenza virus
DJ Smith et al.
SCIENCE (2004)
Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines
S Atabani et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2000)